Invest in iMBP - Learn more

iMetabolic Biopharma Corporation
  • Home
  • build the future
  • Discover our techbio
  • Meet the team
  • invest today
  • More
    • Home
    • build the future
    • Discover our techbio
    • Meet the team
    • invest today
iMetabolic Biopharma Corporation
  • Home
  • build the future
  • Discover our techbio
  • Meet the team
  • invest today

Bring Hope to Communities

Bring Hope to CommunitiesBring Hope to CommunitiesBring Hope to Communities

Through tech-powered biopharma

Learn More

WE IMAGINE A WORLD WHERE PEOPLE LIVE LONGER, HEALTHIER AND HAPPIER LIVES. IT IS BECAUSE OF THE PEOPLE WE LOVE - OUR FAMILIES - THAT WE WORK TOWARDS A WORLD FREE OF DISEASE.

Together, we can be the next stage in developing a revolutionary approach to drug discovery.  We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable.

Meet Our founder

Dr. Urban A. Kiernan

With over 22 years of industry business and research experience, Dr. Urban A. Kiernan is the Founder, Chairman and CEO of iMetabolic Biopharma Corporation (iMBP). 


He is a seasoned BioTech leader with decades of industry business and scientific research experience.  However, his passion is what drives him beyond what any academic or work experience could ever afford him.


Urban, together with an amazing team of experts, are continuously working on the innovative iPlatform™ biotechnology. 

meet the team

The feeling of helplessness I experienced when my first wife died from cancer was devastating. From this pain, I recognized the potential of the biopharma industry and its power to keep families together. This is my passion and this is why I created iMBP.


Dr. Urban A. Kiernan

Invest today

We are proud to support our crowdfunding Reg CF Offering through StartEngine, making investing an efficient and easy process.   Here are some iMBP highlights:  


• A founder with 22 years of combined industry business and research experience

• U.S. Patent for proprietary therapeutic methodology (US/9,783,600)  

• IP provisional filing for iPlatform on January 14th, 2023 

• 5 established disease therapeutic asset programs

• 4 additional programs in preparation to go online 

• Minimum investment of $250

get started

3 CORE PILLARS THAT MAKE IMBP THE FUTURE OF BIOPHARMA

We are the future of drug discovery

Change the way we care for our communities

Support from experts and industry leaders

Our patent-pending technology-powered iPlatform removes roadblocks that make drug development slow, expensive, 

and inefficient.  


Our  computational approach uses in-silico therapeutic discovery and molecular design to improve traditional biotechnology, creating economic & time-saving advantages to drug discovery.  This is the value that TechBio offers to you  and your loved ones. 

Learn more

Support from experts and industry leaders

Change the way we care for our communities

Support from experts and industry leaders

Our revolutionary approach landed us key strategic partnerships, including Amazon Web Services, Ligand Pharmaceuticals, 

and OmniAb.  


iMBP is also proud to be part of the McDermott Wills and Emory LEAP program for corporate legal counsel.


Together, with a group of experienced advisors and executive team, our future has never been brighter.       

Meet the team

Change the way we care for our communities

Change the way we care for our communities

Change the way we care for our communities

BioTech investment opportunities are reserved for an elite circle of the same investors. We are eager to break this cycle by sharing our unique equity crowdfunding campaign  with YOU.   


Give communities the opportunity to directly invest in solutions for their own health. Won’t you join us in transforming the way drugs are developed?



invest today

SUPPORT FROM INDUSTRY LEADERS AND EXPERTS

LEARN HOW A SMALL INVESTMENT COULD CHANGE YOUR FUTURE


Copyright © 2023 iMetabolic Biopharma Corporation - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept